CI Investments Inc’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.7M Sell
367,179
-336,214
-48% -$18.3M 0.05% 222
2026
Q1
$44.1M Sell
703,393
-517,759
-42% -$41.4M 0.21% 103
2025
Q4
$116M Sell
1,221,152
-394,422
-24% -$38.7M 0.51% 45
2025
Q3
$158M Buy
1,615,574
+128,875
+9% +$13.3M 0.57% 33
2025
Q2
$160M Buy
1,486,699
+108,475
+8% +$11M 0.6% 32
2025
Q1
$139M Sell
1,378,224
-269,778
-16% -$27.2M 0.59% 35
2024
Q4
$147M Sell
1,648,002
-25,681
-2% -$2.26M 0.55% 32
2024
Q3
$140M Buy
1,673,683
+5,837
+0.3% +$460K 0.53% 35
2024
Q2
$128M Sell
1,667,846
-196,036
-11% -$14.3M 0.51% 37
2024
Q1
$128M Buy
1,863,882
+629,527
+51% +$40.5M 0.51% 38
2023
Q4
$71.4M Buy
1,234,355
+159,953
+15% +$8.54M 0.37% 69
2023
Q3
$56.7M Buy
1,074,402
+297,155
+38% +$15.6M 0.32% 81
2023
Q2
$42M Sell
777,247
-19,641
-2% -$1.03M 0.21% 110
2023
Q1
$39.9M Buy
796,888
+64,615
+9% +$3.05M 0.2% 117
2022
Q4
$33.9M Sell
732,273
-25,334
-3% -$1.1M 0.17% 127
2022
Q3
$29.3M Sell
757,607
-5,905
-0.8% -$237K 0.15% 137
2022
Q2
$28.5M Sell
763,512
-84,180
-10% -$3.43M 0.13% 148
2022
Q1
$37.5M Sell
847,692
-887,513
-51% -$38.5M 0.14% 152
2021
Q4
$73.7M Sell
1,735,205
-21,668
-1% -$911K 0.25% 107
2021
Q3
$76.2M Sell
1,756,873
-22,814
-1% -$1.01M 0.28% 94
2021
Q2
$76.1M Sell
1,779,687
-1,476,019
-45% -$62.1M 0.28% 98
2021
Q1
$126M Sell
3,255,706
-984,171
-23% -$37.2M 0.53% 51
2020
Q4
$152M Buy
4,239,877
+605,848
+17% +$21.8M 0.67% 45
2020
Q3
$139M Buy
3,634,029
+235,831
+7% +$9.09M 0.69% 38
2020
Q2
$119M Buy
3,398,198
+2,219,376
+188% +$79.9M 0.64% 43
2020
Q1
$38.5M Buy
1,178,822
+128,522
+12% +$5.02M 0.23% 102
2019
Q4
$47.5M Sell
1,050,300
-336,930
-24% -$14.1M 0.24% 111
2019
Q3
$56.4M Buy
1,387,230
+157,833
+13% +$6.69M 0.29% 90
2019
Q2
$52.8M Buy
+1,229,397
New +$47.3M 0.29% 97

Other funds holding BSX

CI Investments Inc's BSX Position: Q2 2026 in Review

CI Investments Inc reduced its Boston Scientific (BSX) stake by 48% in Q2 2026, selling an estimated $18.3M and leaving 367,179 shares worth $15.7M. The position accounts for 0.05% of the portfolio, ranked #222.

CI Investments Inc first reported a position in BSX in Q2 2019 and has held it in 29 quarters since. The position peaked at $160M in Q2 2025. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • CI Investments Inc held 367,179 shares of Boston Scientific worth $15.7M as of Q2 2026.
  • CI Investments Inc sold 336,214 Boston Scientific shares in Q2 2026, an estimated $18.3M.
  • Boston Scientific made up 0.05% of CI Investments Inc's portfolio in Q2 2026, its #222 holding.
  • CI Investments Inc first reported a position in Boston Scientific in Q2 2019 and has held it in 29 quarters since.
  • CI Investments Inc's Boston Scientific position peaked at $160M in Q2 2025.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on CI Investments Inc's 13F filing for Q2 2026, filed 13 Aug 2026.